Somatic Therapies PNLE Questions

Introduction

The live published inventory contains exactly 14 original PNLE-style practice questions on Somatic Therapies. It was last updated August 12, 2026. Use this set as diagnostic practice, not as a claim about actual board questions or a guaranteed exam count.

This topic uses a psychiatric nursing lens for ECT and other biologic or somatic psychiatric treatments. Practice decisions include recognizing treatment purpose, checking whether consent is valid, preparing a patient safely, assessing immediate recovery, explaining expected effects, and distinguishing urgent clinical patterns such as malignant catatonia and neuroleptic malignant syndrome. Psychotropic drug selection or monitoring is outside this page's canonical scope; Psychopharmacology and Psychotherapies are adjacent topics.

Somatic Therapies belongs to NP5, Psychiatric, as a Tangerine pedagogical practice area. In the official framework, it is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS, not a separate official test subject. The 2025 Enhanced TOS provides broad competency relationships rather than a guaranteed weight for this microtopic, so exact topic distribution varies by exam form.

Key concepts

Stay within the somatic-treatment lens
Recognize: The stem is about ECT or another biologic or somatic psychiatric treatment, rather than choosing or monitoring a psychotropic drug.
Decide: Answer from the treatment's purpose, procedure, consent, safety, or teaching context.
Avoid: Importing medication algorithms or psychotherapy techniques into a somatic-treatment question.
Match ECT to the stated clinical aim
Recognize: A question may connect ECT with depression, including psychotic depression, and ask about its purpose or indication.
Decide: Select the option that addresses the clinical aim described in the stem and the patient's immediate need.
Avoid: Choosing an answer because of a broad diagnosis label without identifying what the question is asking the treatment to accomplish.
Protect informed and voluntary consent
Recognize: A valid-consent question may test understanding of the procedure, expected effects, risks, alternatives as applicable, opportunity for questions, and freedom from coercion.
Decide: Verify the authorized consent process and clarify unresolved questions or concerns before proceeding.
Avoid: Treating a signature, family request, or nurse explanation alone as proof of valid consent.
Organize pre-ECT preparation around safety
Recognize: Preparation questions focus on readiness for a controlled procedure and may require checking identity, orders, consent status, assessment findings, and facility requirements.
Decide: Complete the ordered preparation and report discrepancies before the procedure begins.
Avoid: Selecting one isolated preparatory action while ignoring an unresolved safety concern.
Prioritize immediate post-ECT assessment
Recognize: A post-procedure stem requires attention to recovery rather than routine psychiatric teaching first.
Decide: Assess airway and breathing, level of consciousness, orientation, vital stability, and injury risk according to protocol, then provide appropriate supervision.
Avoid: Assuming the patient is ready for routine activity or discharge without an appropriate recovery assessment.
Teach expected effects honestly
Recognize: ECT counseling questions may address temporary confusion, orientation changes, or memory effects after treatment.
Decide: Give clear, balanced teaching, compare findings with the patient's baseline, and report persistent, severe, or unexpected changes through the proper process.
Avoid: Promising that no cognitive effects will occur or presenting every change as automatically dangerous.
Analyze malignant catatonia and neuroleptic malignant syndrome carefully
Recognize: Both urgent patterns can involve altered mental status, severe psychomotor changes, rigidity, fever, or autonomic instability.
Decide: Use medication exposure, movement pattern, associated findings, and the overall clinical course as cues, while escalating instability promptly.
Avoid: Assigning either label from one symptom or delaying action while seeking perfect diagnostic certainty.

What to expect on the PNLE

Use the live inventory to practice several question forms without predicting a future exam form. Representative titles support direct recall of ECT purpose, the biological approach, preparation, and common effects; understanding questions ask what the treatment is intended to accomplish; application questions place the learner in consent, preparation, or post-procedure safety decisions.

The inventory contains 8 easy, 2 medium, and 4 hard questions. Its Bloom distribution is remembering 6, applying 2, understanding 2, analyzing 1, and evaluating 3. These counts describe this published practice set only, not a guaranteed exam pattern. Exact topic distribution varies by exam form, and the 2025 Enhanced TOS does not create a fixed question quota for this microtopic.

Remembering: Retrieve the purpose of ECT, the biologic-treatment concept, preparation principles, and expected effects.
Applying: Select the safest action when the patient needs consent clarification, pre-procedure preparation, or immediate post-ECT assessment.
Analyzing: Separate malignant catatonia from neuroleptic malignant syndrome by integrating multiple cues rather than relying on one finding.
Evaluating: Judge whether consent is adequate, whether teaching is balanced, and whether a proposed nursing action protects the patient.

Study tips

Begin with diagnostic practice. Complete the 14-question inventory without notes, then mark each response as confident, guessed, or missed. For every uncertain item, name the decision involved: purpose, consent, preparation, recovery, teaching, or clinical pattern recognition.
Use focused retrieval for the missed decision. Make a comparison grid that you can reproduce from memory:
Phase or task | Stem cue | Nursing priority
Purpose or indication | Why ECT is being considered | Match the stated clinical aim
Consent | Patient agreement or capacity is questioned | Verify understanding and authorized process
Preparation | Procedure is about to begin | Complete ordered safety checks
Recovery | Patient is immediately post-ECT | Assess stability and supervision needs
Teaching | Patient asks what to expect | Explain expected effects honestly
Review rationales and errors actively. For each wrong answer, write the cue you overlooked, the safest action, and why the distractor was less appropriate. Keep psychotropic selection and monitoring in a separate study file because they are outside this topic's scope.
Retry with spacing. After a delay, answer the missed questions again without looking at the explanation. Rebuild the grid from memory and add only the distinction that corrected your reasoning.
Finish with mixed timed practice. Combine Somatic Therapies with Psychopharmacology and Psychotherapies, then identify which modality the stem addresses before answering. Review time pressure errors separately from knowledge errors, using recall, application, analysis, or evaluation as the supported thinking level.

Common mistakes to avoid

Choosing an answer from the diagnosis alone. A depression label does not identify the question's task. When the stem asks about ECT purpose or indication, use the stated clinical aim and patient context rather than a generalized belief about when ECT is used.
Accepting a signature or family request as complete consent. The cue is language about valid consent. Correct the error by checking understanding, voluntariness, opportunity for questions, and the authorized process when capacity is uncertain.
Applying medication-management thinking to an ECT question. If the stem asks about preparation, recovery, or counseling for a somatic treatment, center the answer on procedural safety and nursing assessment. Do not substitute psychotropic drug selection or monitoring content.
Skipping immediate recovery priorities. A post-ECT question calls for assessment before routine education or activity. Check breathing and airway, consciousness, orientation, vital stability, and injury risk according to protocol.
Overpromising or catastrophizing expected effects. Counseling questions require balanced teaching about possible temporary confusion, orientation changes, or memory effects. Use baseline comparison and follow-up assessment instead of promising no effects or labeling every change as an emergency.
Distinguishing malignant catatonia and neuroleptic malignant syndrome from one sign. Fever or rigidity alone is not enough for a sound conclusion. Consider medication exposure, the movement pattern, associated autonomic findings, and the overall course, while treating severe instability as urgent.

Try a question

A real Somatic Therapies question from our bank. Give it a shot.

Hard

A patient maintains an examiner-imposed arm posture, is mute, febrile, and rigid after antipsychotic escalation. Which interpretation best guides action?

A

Catatonia is likely; focus initial management on psychiatric causes rather than medication-related fever and rigidity.

B

Catatonia is possible; urgently evaluate malignant catatonia, NMS, and medical causes

C

NMS is likely; fixed posture excludes catatonia from the urgent differential

D

Catatonia is possible; a benzodiazepine challenge is the preferred initial step for fever and rigidity.

Rationale

This scenario presents a patient who, after antipsychotic dose escalation, develops mutism, fixed arm posturing (waxy flexibility), fever, and muscular rigidity. Recognizing and responding to these symptoms requires understanding of psychiatric and medical emergencies associated with antipsychotic treatment.

Key Symptom	Clinical Significance
Examiner-imposed posture/waxy flexibility	Suggests catatonia or severe extrapyramidal side effect
Mutism	Classic in catatonia, but also seen in severe illness or delirium
Fever and rigidity	Most concerning for Neuroleptic Malignant Syndrome (NMS), but can be seen in malignant catatonia

Why B is best:

The combination of antipsychotic exposure, fever, rigidity, mutism, and abnormal posturing is highly suggestive of NMS, a life-threatening reaction to dopamine antagonists. However, malignant catatonia presents with fever, rigidity, and autonomic dysfunction, and both can look similar at onset. Differentiating the two is crucial, as initial treatments differ (dopaminergic agents for NMS versus benzodiazepines for catatonia).
Current nursing and psychiatric guidelines (Videbeck, Udan) recommend that new onset of rigidity and fever, particularly after medication changes, must prompt immediate evaluation for life-threatening causes like NMS, malignant catatonia, and other medical etiologies (infection, metabolic derangement). Nursing interventions include holding suspect antipsychotics, notifying the medical team, and preparing for supportive care.
The differential should always remain broad initially; the presence of catatonic signs does NOT exclude NMS, as the two can overlap, especially in the initial clinical presentation.

Analysis of Other Choices:

Option	Why This Is Incorrect
A	If initial management focuses only on psychiatric (primary catatonic) causes, the nurse risks missing NMS, a medical emergency with high mortality if not addressed immediately. Antipsychotic-induced fever and rigidity require urgent medical workup, not just psychiatric assessment.
C	Excluding catatonia solely due to fixed posture is incorrect. Catatonia and NMS can overlap, especially the malignant subtype. Quick exclusion based on posture is not evidence-based and delays necessary life-saving protocol for both possibilities.
D	Although benzodiazepines are first-line in classic catatonia, initiating them before ruling out NMS may be inappropriate if supportive care and withdrawal of antipsychotics are not prioritized. Fever and rigidity post-antipsychotic use require simultaneous evaluation for NMS, a benzodiazepine challenge is not the first step in this setting.

Underlying Concepts:

Nursing process: Prompt assessment, recognition of emergency, and contacting the provider immediately. Safety is a priority.
Pharmacology: Recognizing adverse drug effects, especially rare but fatal syndromes like NMS, is critical for safe medication administration.
Medical-Surgical overlap: Nurses must recognize when psychiatric symptoms can represent medical emergencies due to medication effects.

Clinical Pearls:

Always suspect NMS in psych patients on antipsychotics who develop fever and rigidity, but remember the overlap with catatonic syndromes.
Use the mnemonic "FARM" for NMS: Fever, Autonomic instability, Rigidity, Mental status changes.
Never assume psychiatric symptoms are solely psychiatric, especially after medication changes.

This question tests the nurse's ability to synthesize clinical data with pharmacologic and pathophysiologic knowledge to guide urgent interventions.

British Association for Psychopharmacology. (n.d.). Evidence-based consensus guidelines for catatonia. https://pmc.ncbi.nlm.nih.gov/articles/PMC10101189/
Christman, E., & Ernstmeyer, K. (2025). Nursing Mental Health and Community Concepts 2e. WisTech Open. https://wtcs.pressbooks.pub/nursingmhcc/

References and further reading

PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward.
Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.

How this page is built

The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.

The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.